Clinical trial

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With…

NCT00003888 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed

Key facts

NCT number NCT00003888
Title Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
Official title A Randomized Phase III Multicenter Trial of Neoadjuvant Docetaxel (Taxotere) Plus Cisplatin Plus 5-Fluorouracil Versus Neoadjuvant Cisplatin Plus 5-Fluorouracil in Patients With Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck
Lead sponsor European Organisation for Research and Treatment of Cancer - EORTC, Other
Status Completed
Phase Phase 3
Study type Interventional
Conditions Head and Neck Cancer
Intervention type Drug, Radiation
Interventions cisplatin, docetaxel, fluorouracil, radiation therapy
Enrollment 359
Start date Apr 1, 1999
Primary completion Mar 1, 2002
Completion Mar 1, 2015
First posted Jan 29, 2004
Last update posted Jul 9, 2018
Countries Austria, Belgium, Federal Republic of Yugoslavia, France, Germany, Greece, Hungary, Italy, Netherlands, Poland, Slovakia, Spain and 3 more

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies